Charlson Comorbidity Index (CCI)
iatroX editorial team · Updated · Record checked · editorial policy
The Charlson Comorbidity Index quantifies the burden of comorbid diseases to predict 10-year mortality risk. It assigns weighted scores (1–6) to 19 conditions based on their impact on mortality. The CCI is the most widely used comorbidity index in clinical research.
inputs
evidence
derivation
Developed by Charlson et al. (J Chronic Dis 1987) from a cohort of 559 medical patients admitted to a single hospital. Conditions were weighted by their relative risk for mortality.
validation
Extensively validated in >1,000 published studies across multiple populations and settings. The CCI independently predicts mortality, length of stay, healthcare utilisation, and readmission. An age-adjusted version (Charlson-Deyo) is widely used in administrative database research.
guideline endorsements
Referenced in NICE, ACS NSQIP, and multiple quality improvement frameworks for risk adjustment. Used in research reporting as a standard comorbidity measure.
references
- Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-383.PMID: 3558716
- Quan H, Li B, Couris CM, et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011;173(6):676-682.PMID: 21330339